Click here for text menu (or enable Javascript for regular menu).
Faculty Publications Home

Publications for Jean-Marc Schwarz

  • Cox, C. L., Stanhope, K. L., Schwarz, J. M., Graham, J. L., Hatcher, B., Griffen, S. C., . . . Havel, P. J. (2011). Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks. The Journal of Clinical Endocrinology and Metabolism, 96(12), E2034-E2038.

  • Cox, C. L., Stanhope, K. L., Schwarz, J. M., Graham, J. L., Hatcher, B., Griffen, S. C., . . . Keim, N. L. (2011). Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women. European Journal of Clinical Nutrition, 66(2), 201-208.

  • Dyachenko, A., Patel, S., Pham, A., Lin, S., Tang, D., Wen, M., & Schwarz, J. M. (2011). Impact of oral glucose tolerance test on hepatic glycogen and de novo lipogenesis. Journal of the American Osteopathic Association, 111(8), 497.

  • Johannsen, D. L., Schwarz, J. M., & Ravussin, E. (2011). Deposition of Lipid in the Liver, but Not Other Ectopic Depots, during 8-Weeks Overfeeding Reduces Insulin Sensitivity in Young Adults. Diabetes, 60(Suppl. 1), A415, 1511.

  • Smith, T. J., Schwarz, J. M., Montain, S. J., Rood, J., Pikosky, M. A., Castaneda-Sceppa, C., . . . Young, A. J. (2011). High protein diet maintains glucose production during exercise-induced energy deficit: A controlled trial. Nutrition and Metabolism, 8, 26.

  • Stanhope, K. L., Griffen, S. C., Bremer, A. A., Vink, R. G., Schaefer, E. J., Nakajima, K., . . . Havel, P. J. (2011). Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. The American Journal of Clinical Nutrition, 94(1), 112-119.

  • Rao, M., Mulligan, K., Tai, V., Wen, M., Dyachenko, A., Weinberg, M., & Schambelan, M. (2010). Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance. Journal of Clinical Endocrinology and Metabolism, 95(9), 4361-4366. This material can be found here.

  • Mulligan, K., Khatami, H., Schwarz, J. M., Sakkas, G. K., DePaoli, A. M., Tai, V. W., . . . Schambelan, M. (2009). The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. Journal of Clinical Endocrinology and Metabolism, 94(4):1137-1144. doi: 10.1210/jc.2008-1588 This material can be found here.

  • Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., . . . Havel, P. J. (2009). Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. The Journal of Clinical Investigation, 119(5), 1322-1334. doi: 10.1172/JCI37385. This material can be found here.